HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Market News Stocks News ETF News Crypto News

Royalty Pharma plc

Contributing Author

Recent Articles by Royalty Pharma plc

Nov-05
Royalty Pharma Reports Third Quarter 2025 Results RPRX GlobeNewswire
Nov-04
Royalty Pharma Acquires Royalty Interest in Alnylam's AMVUTTRA for $310 Million from Blackstone Life Sciences RPRX GlobeNewswire
Oct-17
Royalty Pharma Declares Fourth Quarter 2025 Dividend RPRX GlobeNewswire
Oct-09
Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025 RPRX GlobeNewswire
Sep-29
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director RPRX GlobeNewswire
Sep-19
Royalty Pharma to Present at Bernstein's 2nd Annual Healthcare Forum RPRX GlobeNewswire
Sep-11
Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company's Plans to Drive Value Creation RPRX GlobeNewswire
Sep-10
Royalty Pharma Announces Release of Deloitte's Report on the Biopharma Royalty Market RPRX GlobeNewswire
Sep-04
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference RPRX GlobeNewswire
Sep-02
Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes RPRX GlobeNewswire
Sep-02
Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million RPRX GlobeNewswire
Aug-25
Royalty Pharma to Acquire Royalty Interest in Amgen's Imdelltra for up to $950 Million RPRX GlobeNewswire
Aug-13
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors RPRX GlobeNewswire
Aug-06
Royalty Pharma Reports Second Quarter 2025 Results RPRX GlobeNewswire
Jul-18
Royalty Pharma Declares Third Quarter 2025 Dividend RPRX GlobeNewswire
Jul-17
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company's Board of Directors RPRX GlobeNewswire
Jul-16
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025 RPRX GlobeNewswire
Jun-24
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion RPRX GlobeNewswire
Jun-04
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference RPRX GlobeNewswire
May-16
Royalty Pharma Completes the Acquisition of Its External Manager RPRX GlobeNewswire
May-13
Royalty Pharma to Present at Upcoming Investor Conferences RPRX GlobeNewswire
May-12
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition RPRX GlobeNewswire
May-08
Royalty Pharma Reports First Quarter 2025 Results RPRX GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.